Hospira’s Web Notice Discontinuing Execution Drug Has Global Implications - But Will Executions Stop? No: Meet Besse Medical of Ohio

more+
less-

On January 21, 2011, via its website, Illinois drug manufacturer Hospira, Inc. fired a shot heard ‘round the world as it announced in a short and sweet press release that it would no longer be making sodium thiopental (product name, Pentothal™). According to Hospira:

Hospira had intended to produce Pentothal at its Italian plant. ... [W]e cannot take the risk that we will be held liable by the Italian authorities if the product is diverted for use in capital punishment. Exposing our employees or facilities to liability is not a risk we are prepared to take.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Health Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Terence Lenamon | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »